Michael Sandhu is a specialist in delivering cancer solutions. Michael has over 30 years of experience having worked for industry market leaders over this period.
Michael qualified with a BA(Hons) degree in Medical Sciences in 1984 and, after a short period in the UK public healthcare sector moved into the radiation therapy field gaining extensive experience in worldwide markets outside of the Americas as Vice President Sales and Marketing for these regions with Varian Medical Systems.
Michael specialized in Sales and Marketing Operations and lead as the public-private partnership (PPP) Director in the development and implementation of PPP projects worldwide for Varian, following the first pioneering PPP projects in the UK in the 1990s.
Michael recently led the Market Access team to develop cancer and radiation therapy solutions in emerging markets for Varian working at ministerial levels of government, and senior levels in UN agencies and key Cancer NGOs. Michael has hosted international workshops on developing advanced cancer solutions for emerging markets.
In 2018 there were approximately 18 million cancer cases globally with close to 10 million deaths. This is set to rise to almost 20 million cases and 12 million deaths by 2025. Radiation Therapy is known to be effective in 60% cases and curative in 40% of all cases yet unavailable to 80% of the world population with an estimated shortage of some 20,000 units to treat all these cancer cases. Michael has set up remediumRT, a specialist consultancy company based out of Zug, Switzerland to help bridge this gap.